Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nucleocapsid mutations in SARS-CoV-2 augment replication and pathogenesis
Bryan A. Johnson, Yiyang Zhou, Kumari G. Lokugamage, et al.
PLoS Pathogens (2022) Vol. 18, Iss. 6, pp. e1010627-e1010627
Open Access | Times Cited: 129

Showing 1-25 of 129 citing articles:

SARS-CoV-2 variant biology: immune escape, transmission and fitness
Alessandro M. Carabelli, Thomas P. Peacock, Lucy Thorne, et al.
Nature Reviews Microbiology (2023)
Open Access | Times Cited: 969
The evolution of SARS-CoV-2
Peter V. Markov, Mahan Ghafari, Martin Beer, et al.
Nature Reviews Microbiology (2023) Vol. 21, Iss. 6, pp. 361-379
Open Access | Times Cited: 761
Low neutralization of SARS-CoV-2 Omicron BA.2.75.2, BQ.1.1 and XBB.1 by parental mRNA vaccine or a BA.5 bivalent booster
Chaitanya Kurhade, Jing Zou, Hongjie Xia, et al.
Nature Medicine (2022) Vol. 29, Iss. 2, pp. 344-347
Open Access | Times Cited: 380
The outbreak of SARS‐CoV‐2 Omicron lineages, immune escape, and vaccine effectivity
Yongbing Zhou, Hui‐Lin Zhi, Yong Teng
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Open Access | Times Cited: 132
SARS-CoV-2 variants evolve convergent strategies to remodel the host response
Mehdi Bouhaddou, Ann‐Kathrin Reuschl, Benjamin J. Polacco, et al.
Cell (2023) Vol. 186, Iss. 21, pp. 4597-4614.e26
Open Access | Times Cited: 68
Less neutralization evasion of SARS-CoV-2 BA.2.86 than XBB sublineages and CH.1.1
Yanping Hu, Jing Zou, Chaitanya Kurhade, et al.
Emerging Microbes & Infections (2023) Vol. 12, Iss. 2
Open Access | Times Cited: 46
Interaction between host G3BP and viral nucleocapsid protein regulates SARS-CoV-2 replication and pathogenicity
Zemin Yang, Bryan A. Johnson, Victoria Meliopoulos, et al.
Cell Reports (2024) Vol. 43, Iss. 3, pp. 113965-113965
Open Access | Times Cited: 25
Evolution of the SARS-CoV-2 Omicron Variants: Genetic Impact on Viral Fitness
Wenhao Liu, Zehong Huang, Jin Xiao, et al.
Viruses (2024) Vol. 16, Iss. 2, pp. 184-184
Open Access | Times Cited: 21
Comparison of SARS-CoV-2 variants of concern in primary human nasal cultures demonstrates Delta as most cytopathic and Omicron as fastest replicating
Nikhila S. Tanneti, Anant K. Patel, Li Tan, et al.
mBio (2024) Vol. 15, Iss. 4
Open Access | Times Cited: 19
TRIM28-mediated nucleocapsid protein SUMOylation enhances SARS-CoV-2 virulence
Jiang Ren, Shuai Wang, Zhi Zong, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 18
Within-host evolutionary dynamics and tissue compartmentalization during acute SARS-CoV-2 infection
Mireille Farjo, Katia Koelle, Michael A. Martin, et al.
Journal of Virology (2024) Vol. 98, Iss. 1
Open Access | Times Cited: 17
Unique mutations in SARS-CoV-2 Omicron subvariants' non-spike proteins: Potential impacts on viral pathogenesis and host immune evasion
Anamica Hossain, Shammi Akter, Alfi Anjum Rashid, et al.
Microbial Pathogenesis (2022) Vol. 170, pp. 105699-105699
Open Access | Times Cited: 63
SARS-CoV-2 Inhibits NRF2-Mediated Antioxidant Responses in Airway Epithelial Cells and in the Lung of a Murine Model of Infection
Yue Qu, Aline Haas de Mello, Dorothea R. Morris, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 3
Open Access | Times Cited: 34
A conserved oligomerization domain in the disordered linker of coronavirus nucleocapsid proteins
Huaying Zhao, Di Wu, Sergio A. Hassan, et al.
Science Advances (2023) Vol. 9, Iss. 14
Open Access | Times Cited: 31
Protein post-translational modification in SARS-CoV-2 and host interaction
Nana Cheng, Mingzhu Liu, Wanting Li, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 27
SARS-CoV-2 Uses Nonstructural Protein 16 To Evade Restriction by IFIT1 and IFIT3
Craig Schindewolf, Kumari G. Lokugamage, Michelle N. Vu, et al.
Journal of Virology (2023) Vol. 97, Iss. 2
Open Access | Times Cited: 27
SARS-CoV-2 Omicron (B.1.1.529) Variant: A Challenge with COVID-19
Zeinab Mohseni Afshar, Ali Tavakoli Pirzaman, Bardia Karim, et al.
Diagnostics (2023) Vol. 13, Iss. 3, pp. 559-559
Open Access | Times Cited: 23
Resistance mechanisms of SARS-CoV-2 3CLpro to the non-covalent inhibitor WU-04
Lijing Zhang, Xuping Xie, Hannan Luo, et al.
Cell Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 12
Comprehensive Review of COVID-19: Epidemiology, Pathogenesis, Advancement in Diagnostic and Detection Techniques, and Post-Pandemic Treatment Strategies
Y.-C. Chung, Ching-Yin Lam, Pak-Hei Tan, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8155-8155
Open Access | Times Cited: 10
The NSP3 protein of SARS-CoV-2 binds fragile X mental retardation proteins to disrupt UBAP2L interactions
Dimitriya H. Garvanska, R. Elias Alvarado, Filip Mundt, et al.
EMBO Reports (2024) Vol. 25, Iss. 2, pp. 902-926
Open Access | Times Cited: 9
Assembly of SARS-CoV-2 nucleocapsid protein with nucleic acid
Huaying Zhao, Abdullah M. Syed, Mir M. Khalid, et al.
Nucleic Acids Research (2024) Vol. 52, Iss. 11, pp. 6647-6661
Open Access | Times Cited: 9
Impact of mutations on the stability of SARS-CoV-2 nucleocapsid protein structure
Nelli Muradyan, Vahram Arakelov, Arsen Sargsyan, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 8
Emergence of SARS-CoV-2 subgenomic RNAs that enhance viral fitness and immune evasion
Harriet V Mears, George R. Young, Theo Sanderson, et al.
PLoS Biology (2025) Vol. 23, Iss. 1, pp. e3002982-e3002982
Open Access | Times Cited: 1
Low neutralization of SARS-CoV-2 Omicron BA.2.75.2, BQ.1.1, and XBB.1 by 4 doses of parental mRNA vaccine or a BA.5-bivalent booster
Chaitanya Kurhade, Jing Zou, Hongjie Xia, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 33
Assembly of SARS-CoV-2 ribonucleosomes by truncated N∗ variant of the nucleocapsid protein
Armin N. Adly, Maxine Bi, Christopher R. Carlson, et al.
Journal of Biological Chemistry (2023) Vol. 299, Iss. 12, pp. 105362-105362
Open Access | Times Cited: 19
Page 1 - Next Page

Scroll to top